Click to Share

Antiviral Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By TSRL, Inc.
Therapeutic Systems Research Laboratories (TSRL), Inc., announced today that the company was awarded a Phase I SBIR grant from the National Institute of Allergy & Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
By Anthony Codispoti
Green Tea's powerful antioxidant, EGCG, has been shown to effectively inhibit the ability of certain viruses to reproduce.
By has announced the addition of “How to Enhance the Value of Antiviral Therapies Through Biomarkers and Diagnostics.” This report focuses on how recent R&D innovations in biomarker diagnostics are improving antiviral treatments
By Bharatbook
Bharatbook added a new report on "Global Antivirals Market 2010-2025" assesses the leading companies, with their performances in the antivirals market predicted.
The first doses of influenza A (H1N1) vaccine could be available within five to six months after identification of the new virus.
By Roger Brown, Ph.D.
GlycoMeds has filed a request for an Emergency Use Authorization with the FDA under the authority of the CDC. If issued this would allow sale as a medication to proceed prior to the upcoming flu season.

Page updated every 10 minutes

Like PRLog?
Click to Share